1 week Ago By Defense World Staff
KLP Kapitalforvaltning AS purchased a new position in shares of Quanterix Co. ( NASDAQ:QTRX – Free Report ) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 6,200 shares of the company’s stock, valued at approximately $66,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. William Blair Investment Management LLC bought a new stake in shares of Quanterix during the 4th quarter worth $11,290,000. Valmark Advisers Inc.
increased its holdings in Quanterix by 88.3% during the fourth quarter. Valmark Advisers Inc.
now owns 210,878 shares of the company’s stock worth $2,242,000 after buying an additional 98,883 shares during the last quarter. Graypoint LLC bought a new stake in Quanterix in the fourth quarter worth about $691,000. Raymond James Financial Inc.
purchased a new position in Quanterix in the fourth quarter valued at about $570,000. Finally, JPMorgan Chase & Co. grew its position in shares of Quanterix by 28.
1% during the 3rd quarter. JPMorgan Chase & Co. now owns 217,957 shares of the company’s stock valued at $2,825,000 after acquiring an additional 47,873 shares during the period.
Hedge funds and other institutional investors own 86.48% of the company’s stock. Analyst Ratings Changes QTRX has been the topic of a number of research reports.
Scotiabank reaffirmed an “outperform” rating on shares of Quanterix in a report on Tuesday, March 25th. Canaccord Genuity Group dropped their price target on Quanterix from $20.00 to $15.
00 and set a “buy” rating on the stock in a research report on Tuesday, March 18th. Quanterix Trading Up 8.1 % QTRX opened at $5.
20 on Friday. Quanterix Co. has a 12 month low of $4.
67 and a 12 month high of $19.71. The company has a market cap of $201.
64 million, a PE ratio of -4.91 and a beta of 1.35.
The company has a 50 day moving average of $7.09 and a 200 day moving average of $10.01.
Quanterix ( NASDAQ:QTRX – Get Free Report ) last announced its quarterly earnings results on Monday, March 17th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.
27) by ($0.03). The company had revenue of $35.
16 million during the quarter, compared to analysts’ expectations of $34.93 million. Quanterix had a negative net margin of 30.
12% and a negative return on equity of 11.74%. Research analysts forecast that Quanterix Co.
will post -0.98 earnings per share for the current fiscal year. About Quanterix ( Free Report ) Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. Featured Stories Five stocks we like better than Quanterix Technology Stocks Explained: Here’s What to Know About Tech JPMorgan is a Buy, if You Can Handle The Volatility How to Profit From Growth Investing United States Steel’s Crash: An Unmissable Buying Opportunity 5 Top Rated Dividend Stocks to Consider Rocket Lab Stock: Weathering the Storm, Time for a Comeback? Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter .
.
